Cencora price target raised to $313 from $288 at Morgan Stanley

Morgan Stanley analyst Erin Wright raised the firm’s price target on Cencora (COR) to $313 from $288 and keeps an Equal Weight rating on the shares following what the firm calls “another standout” quarter. U.S. Healthcare exceeded expectations yet again, which largely contributed to the FY25 EPS increase, says the analyst, who points out that this marks the fourth time Cencora has raised EPS guidance since issuing in November as the segment continually surpasses plan.